Search for Clinical Trial Results
Hepatoblastoma - 26 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy Condition:
|
Active, not recruiting |
Study Name: Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors Condition:
|
Completed |
Study Name: A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB Condition:
Interventions: Drug: LDE225 LDE225/sonidegib capsules were supplied to the Investigators at dose strengths of 50 mg, 10 |
Not yet recruiting |
Study Name: Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors Condition:
|
Not yet recruiting |
Study Name: G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor Condition:
|
Recruiting |
Study Name: Understanding Communication in Healthcare to Achieve Trust (U-CHAT) Condition:
|
Recruiting |
Study Name: Auto Transplant for High Risk or Relapsed Solid or CNS Tumors Condition:
|
Withdrawn |
Study Name: Imetelstat Sodium in Treating Younger Patients With Relapsed or Refractory Solid Tumors Condition:
|
Recruiting |
Study Name: Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors Condition:
Interventions: |